AMS Launches New GreenLight(TM) XPS Laser Therapy System at the American Urological Association’s (AUA) Annual Meeting in San Francisco May 29-June 3
MINNETONKA, Minn., May 28 /PRNewswire-FirstCall/ — American Medical SystemsÃ‚® (AMS) (Nasdaq: AMMD), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the launch and immediate availability of its new GreenLight XPS (Xcelerated Performance System) for laser treatment of benign prostatic hyperplasia (BPH) or enlarged prostate.
Built upon the technology and performance of AMS’ GreenLight PVÃ‚® and HPS laser systems, the new GreenLight XPS offers enhanced treatment efficiency with extended fiber longevity and improved coagulation capabilities over other laser therapy treatment systems. GreenLight(TM) has proven to deliver results equivalent to TURP, with lower morbidity, fewer complications, shorter hospital stays and lower overall cost.
“GreenLight XPS provides the most compelling alternative to TURP therapies and furthers our commitment to fostering a new standard of care for treating enlarged prostate,” said Joe Martin, Senior Vice President and General Manager of BPH Therapies at AMS. “With these advances in our GreenLight system, we’re one step closer to realizing our vision of a world without TURP and its bothersome side effects.”
Faster, More Efficient Treatment with Greater Fiber Longevity
GreenLight XPS significantly improves vaporization efficiency leading to a reduction in treatment time without impacting the depth of tissue removal or coagulation.
The XPS system features FiberLife(TM), an automatic safety feature that decreases fiber-related failures by up to 90 percent resulting in increased longevity, enabling the treatment of glands larger than 100g with a single fiber.
“I am very pleased with the performance of the new GreenLight laser,” said Ricardo Gonzalez, M.D., Houston Metro Urology/Baylor College of Medicine, who participated in the clinical evaluation of the GreenLight XPS Laser System. “The new FiberLife feature improves procedural efficiency and fiber reliability allowing treatment of larger glands with one fiber.”
GreenLight XPS is the latest in AMS’ portfolio of innovative, technologically advanced solutions to treat enlarged prostate. Through its commitment to innovation and continuous improvement, AMS has become the recognized technology leader in both the men’s and women’s pelvic health markets. For more information about GreenLight XPS, visit www.AMSGreenLight.com.
About American Medical Systems:
American Medical Systems, headquartered in Minnetonka, Minnesota, is a diversified supplier of medical devices and procedures to cure incontinence, erectile dysfunction, benign prostate hyperplasia (BPH), pelvic floor repair and other pelvic disorders in men and women. These disorders can significantly diminish one’s quality of life and profoundly affect social relationships. In recent years, the number of people seeking treatment has increased markedly as a result of longer lives, higher-quality-of-life expectations and greater awareness of new treatment alternatives. American Medical Systems’ products reduce or eliminate the incapacitating effects of these diseases, often through minimally invasive therapies. The Company’s products were used to treat more than 335,000 patients in 2009.
More information about the Company and its products can be found at its website www.AmericanMedicalSystems.com and in the Company’s Annual Report on Form 10-K for 2009 and its other SEC filings.
Investor Relations Contact: Mark Heggestad American Medical Systems 952-930-6495 mark.heggestad@AMMD.com
SOURCE American Medical Systems, Inc.